Amarin Corp Plc (AMRN)

[ziploc_1]

The Dow is down well over 100 points in the pre-market today..and, even though the CDC and FDA have been openly criticizing Pfizer for its questionably premature announcement of developing a booster shot for its mRNA vaccine, the PFE stock price has not been hurt in the premarket....This is the polar opposite of how Amarin has been conservatively managing its press releases...Pfizer is setting a good example as to how Amarin should be handing its PR's more aggressively.